Skip to content
← Back to Publish Online

Anesthetic management in a patient with marsili syndrome: A case reportand review of literature

Anesthetic management in marsili syndrome

Case Report DOI: 10.4328/ACAM.22747

Authors

Affiliations

1Department of Anesthesiology and Critical Care, Faculty of Medicine, Karadeniz Technical University, Trabzon, Türkiye

Corresponding Author

Abstract

Introduction Marsili syndrome is a rare congenital disorder characterized by markedly reduced pain perception with preserved tactile and proprioceptive functions. Altered nociception presents unique challenges for anesthetic management, particularly regarding analgesic dosing and intraoperative monitoring.
Case Presentation A 17-year-old male with Marsili syndrome underwent surgical debridement of an infected leg prosthesis. Preoperative assessment revealed diminished pain and temperature sensation, lip atrophy, and a potentially difficult airway. General anesthesia was induced and maintained with propofol and remifentanil, guided by bispectral index (BIS) monitoring. The intraoperative course was uneventful, with stable hemodynamic parameters, and no postoperative analgesia was required.
Conclusion This case demonstrates that safe anesthetic management in patients with Marsili syndrome can be achieved through individualized, carefully titrated anesthetic techniques and vigilant monitoring. Further clinical experience is required to establish standardized anesthetic guidelines for this rare condition.

Keywords

Marsili Syndrome Congenital Hypoalgesia Anesthesia Pain Insensitivity

Introduction

Balestrini and colleagues were the pioneers in defining Marsili syndrome, a rare congenital condition characterized by hypoalgesia 1. This syndrome is marked by an extraordinarily elevated threshold for pain perception. Individuals affected often endure severe problems such as burns, fractures, or infections without awareness. Remarkably, other sensory modalities, including tactile perception, thermal sensation, and proprioception, remain mostly unimpacted by this condition. A rare mutation in the zinc finger homeobox 2 (ZFHX2) gene has been associated with Marsili syndrome. This gene is thought to modulate neuronal transcription factors associated with the perception of pain 2.
Marsili syndrome poses multiple challenges in the context of anesthetic practice. For these patients, traditional pain-based anesthetic and analgesic monitoring may prove ineffective. There may be little objective (hemodynamic alterations) or subjective (patient’s account) responses to pain. Consequently, the necessity for analgesia may be obscured by the postoperative stress response, leading to either inadequate or excessive analgesic administration 3. Nonetheless, the inability to sense pain may result in surgical complications remaining undetected.
One of the most critical characteristics of the disease is its ability to progress alongside normal motor and cognitive development, despite significant impairment in pain perception. Consequently, individuals often proceed with their lives oblivious to significant harm. Impaired thermal awareness, insensitivity to high temperatures, susceptibility to dermal infections, and protracted healing post-trauma are supplementary findings that may constitute the clinical presentation. Patients must be meticulously assessed for all of these attributes during surgical interventions. This case report pertains to a young patient diagnosed with Marsili syndrome undergoing orthopedic surgery. This case is presented to enhance awareness of the limited recorded occurrences of anesthesia administration in individuals with this rare illness.

Case Presentation

An orthopedic clinic referred a 17-year-old male patient with Marsili syndrome to anesthesia for debridement and cleansing due to an infection in his right leg prosthesis. The laboratory results and chest X-ray from the preoperative assessment were normal. The patient demonstrated a mild cognitive impairment and was compliant and oriented during the physical assessment. Persistent chewing resulted in atrophy of the lower lip (Figure 1-2), and the dorsal surfaces and digits of both hands exhibited abnormalities (Figure 3). The patient’s feeling of pain and temperature was markedly diminished; they reported having pain but could not identify its specific location. The tactile perception was preserved.
The sternomental distance was evaluated as 10 cm, and the Mallampati score was recorded as IV during the preoperative airway assessment. Informed consent was obtained after the patient’s family members were thoroughly briefed on the anesthesia method to be employed and any associated risks. Informed consent was obtained from the patient.
The patient was observed in the operating room utilizing BIS, temperature assessment, and standard monitoring techniques (electrocardiography, non-invasive arterial pressure measurement, and pulse oximetry). The initial vital signs recorded were: blood pressure of 100/50 mmHg, heart rate of 84 beats per minute, and SpO₂ of 99%. In the case of a difficult airway, the necessary equipment was readily available. Intravenous midazolam (0.05 mg/kg) was administered as premedication. A size 4 laryngeal mask was subsequently positioned with comfort following the administration of 3 mg/kg of propofol for induction. Propofol and remifentanil were administered to maintain the BIS value between 40 and 60 during anesthesia, using a gas mixture of 50% oxygen and 50% air.
The approximately one-hour surgical procedure was completed without complications. Infusions were terminated at the end of the surgery, and 100% oxygen was administered for ventilation. The patient, with a BIS score of 85 and spontaneous respiration, experienced no difficulty in removing the laryngeal mask. During the postoperative phase, the patient did not require any supplementary analgesics.
Our manuscript is a single case report; therefore, formal ethics committee approval was not sought, as it does not constitute a case series or research involving multiple subjects. Informed consent for publication, including the use of clinical images, was obtained from the patient. To ensure patient confidentiality, identifying features in the photographs have been adequately anonymized.

Discussion

Individuals with Marsili syndrome, a rare congenital condition, have a significant reduction in their perception of pain. The literature has not sufficiently addressed the challenges this condition poses for anesthetic operations. The surgical stress response is not completely absent in individuals with Marsili syndrome, despite their absence of conscious pain awareness. The autonomic system may persist in eliciting reactions such as tachycardia, hypertension, and hormonal alterations 4. Individuals with congenital insensitivity to pain still require anesthesia; nevertheless, it necessitates meticulous analgesic planning to ensure intraoperative stability 5.
The patient’s hemodynamic responses were stable when propofol and remifentanil were administered in conjunction with minimal to no opioids for anesthesia. This suggests that individuals with Marsili syndrome may find low-dose mixtures of opioids and non-opioids sufficient. Nonetheless, there exists a possibility of either excessive or insufficient analgesia if behavioral feedback regarding pain is unattainable. The lack of pain feedback may increase the likelihood of postoperative respiratory depression, especially with the administration of strong opioid dosages. Consequently, titration-based and multimodal analgesia methods are recommended for these individuals 6.
The patient in our case exhibits facial deformities resulting from lip atrophy, posing a risk of difficult airway and intubation; thus, it is essential to prepare the case with difficult airway equipment readily available.
The absence of pain indicators in these patients throughout the postoperative period may result in possible issues remaining undetected. Patients may fail to disclose an infected surgical wound or one compromised by a hematoma due to the absence of pain. Consequently, it is imperative to meticulously observe through clinical examination, ocular inspection, and laboratory results (such as CRP and leukocyte count).
Marsili syndrome has been associated with issues related to perspiration and insensitivity to cold 1. Body temperature throughout the intraoperative period. In this case, thermal dissipation throughout the procedure was reduced, and the patient’s temperature was meticulously observed. Each patient must have their temperature regulation, cardiac stability, and fluid-electrolyte balance evaluated separately, as numerous congenital hypoalgesia illnesses are linked to autonomic dysfunctions.
Effective analgesia relies on an objective evaluation of the body’s nociceptive responses, even in the absence of pain perception or the inability to induce a subjective reaction. The NOL (Nociception Level) device may objectively assess physiological indicators to ascertain the presence and intensity of nociception in patients, independent of their subjective pain perception. The NOL index’s efficacy in evaluating intraoperative nociceptive activity in adult and pediatric patients has been substantiated in the literature 7.
Due to the absence of the necessary equipment in our clinic, we were unable to utilize it for this patient. There is a scarcity of material regarding the application of anesthesia in individuals with Marsili syndrome, namely HSAN type IV or V, for which supplementary information exists. This case study demonstrates that an individual with Marsili syndrome can undergo anesthesia safely and be treated satisfactorily. It is clear, however, that personalized anesthetic treatments should replace traditional methods for these individuals.

Limitations

This case report provides important insights into the anesthetic management of a patient with Marsili syndrome; however, its findings are limited by the single-patient nature of the study. The absence of advanced nociception monitoring tools, such as the NOL index, may have hindered accurate assessment of intraoperative analgesic needs. Additionally, the lack of standardized anesthetic protocols for this rare condition necessitated an individualized approach, which may not be applicable to all similar cases.

Conclusion

Although patients with Marsili syndrome lack subjective pain perception, their anesthetic management requires a distinct approach compared to conventional protocols. This case highlights that, with careful preoperative planning and vigilant intraoperative monitoring, individualized, titration-based, and multimodal anesthesia strategies can be applied both safely and effectively. Nonetheless, due to the rarity of this condition, further comprehensive case series and systematic studies are essential to establish evidence-based anesthetic guidelines for this unique patient population.

Declarations

Animal and Human Rights Statement

All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed Consent

Written informed consent was obtained from the patient for publication of this case report and accompanying images. The patient was informed that identifying information would be removed to protect confidentiality, but that complete anonymity could not be guaranteed.

Data Availability

The datasets used and/or analyzed during the current study are not publicly available due to patient privacy reasons but are available from the corresponding author on reasonable request.

Conflict of Interest

The authors declare that there is no conflict of interest.

Funding

None.

Scientific Responsibility Statement

The authors declare that they are responsible for the article’s scientific content, including study design, data collection, analysis and interpretation, writing, and some of the main line, or all of the preparation and scientific review of the contents, and approval of the final version of the article.

References

  1. Xiong XM, Wei XY, Wang HY, Wen ZG. Marsili syndrome manifested by fever: a case report and literature review. Zhonghua Jie He He Hu Xi Za Zhi. 2022;45(7):686-91. doi:10.3760/cma.j.cn112147-20211130-00848
  2. Habib AM, Matsuyama A, Okorokov AL, et al. A novel human pain insensitivity disorder caused by a point mutation in ZFHX2. Brain. 2018;141(2):365-76. doi:10.1093/brain/awx326
  3. Akdoğan A, Eroğlu A, Kutanis D, Cekic B. Anesthetic management in a patient with congenital insensitivity to pain syndrome for lower extremity surgery. Int J Anesth Res. 2016;4(10):340–2. doi:10.19070/2332-2780-1600070
  4. Zhang Y, Geng Z. Anesthetic management of a child with congenital insensitivity to pain with anhidrosis: a case report. Front Surg. 2022;9:997162. doi:10.3389/fsurg.2022.997162
  5. Zlotnik A, Natanel D, Kutz R, et al. Anesthetic management of patients with congenital insensitivity to pain with anhidrosis: a retrospective analysis of 358 procedures performed under general anesthesia. Anesth Analg. 2015;121(5):1316-20. doi:10.1213/ANE.0000000000000912
  6. Özmete Ö, Şener M, Bali Ç, Çalışkan E, Arıboğan A. Congenital insensitivity to pain: How should anesthesia be managed? Turk J Pediatr. 2017;59(1):87-9. doi:10.24953/turkjped.2017.01.016
  7. Huiku M, Uutela K, van Gils M, et al. Assessment of surgical stress during general anaesthesia. Br J Anaesth. 2007;98(4):447-55. doi:10.1093/bja/aem004

Additional Information

Publisher’s Note
Bayrakol MP remains neutral with regard to jurisdictional and institutional claims.

Rights and Permissions

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0). To view a copy of the license, visit https://creativecommons.org/licenses/by-nc/4.0/

About This Article

How to Cite This Article

Ceren Nur Duygun Sahin, Ali Akdogan. Anesthetic management in a patient with marsili syndrome: A case report and review of literature. Ann Clin Anal Med 2025; DOI: 10.4328/ACAM.22747

Received:
May 18, 2025
Accepted:
July 14, 2025
Published Online:
July 22, 2025